Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Qiagen Reports Positive Trial for FastHPV Test in China

publication date: Nov 8, 2007
Qiagen, the Dutch diagnostic testing company, announced that its FastHPV Test, an affordable test for HPV designed for use in low-resource areas of the world, passed a clinical trial conducted in China. The trial enrolled 2,500 women, aged 30 to 54, most of whom live in rural areas of China. Once finalized, the results from the test will be used to support a request for market approval of the FastHPV test. The request will initially be submitted in China and India in 2008. More details...

Stock Symbol:  (NSDQ:QGEN)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here